Cardiol Therapeutics Inc. (CRDL)
NASDAQ: CRDL · Real-Time Price · USD
0.9931
-0.0169 (-1.67%)
At close: Dec 26, 2025, 4:00 PM EST
0.9997
+0.0066 (0.66%)
After-hours: Dec 26, 2025, 7:16 PM EST
Cardiol Therapeutics Market Cap
Cardiol Therapeutics has a market cap or net worth of $99.74 million as of December 26, 2025. Its market cap has decreased by -15.15% in one year.
Market Cap
99.74M
Enterprise Value
91.34M
1-Year Change
-15.15%
Ranking
Category
Stock Price
$0.99
Market Cap Chart
Since December 20, 2018, Cardiol Therapeutics's market cap has increased from $69.77M to $99.74M, an increase of 42.96%. That is a compound annual growth rate of 5.23%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 24, 2025 | 99.74M | -4.94% |
| Dec 31, 2024 | 104.92M | 93.06% |
| Dec 29, 2023 | 54.35M | 67.34% |
| Dec 30, 2022 | 32.48M | -71.06% |
| Dec 31, 2021 | 112.23M | 56.56% |
| Dec 31, 2020 | 71.68M | -21.55% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 20, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 964.31B |
| Johnson & Johnson | 500.60B |
| AbbVie | 406.30B |
| UnitedHealth Group | 296.73B |
| AstraZeneca | 286.29B |
| Novartis AG | 267.64B |
| Merck & Co. | 264.21B |
| Novo Nordisk | 232.28B |